• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Anal Chim Acta . Synergistic dual-signal amplification aptasensor and AuNPs@TtTp COF-based SERS platform for ultrasensitive detection of SARS-CoV-2 re

tetano

Editor, Senior Moderator
Anal Chim Acta

. 2026 Dec 1:1425:346302.
doi: 10.1016/j.aca.2026.346302. Epub 2026 Sep 23.

Synergistic dual-signal amplification aptasensor and AuNPs@TtTp COF-based SERS platform for ultrasensitive detection of SARS-CoV-2 receptor-binding domain​


Anabadya Pal 1 , Ankur Chaudhuri 2 , Md Azaharuddin 1 , Amitesh Roy 3 , Soumajit Chakrabarty 1 , Susmita Nandi 1 , Saikat Chakrabarti 2 , Tarakdas Basu 4

Affiliations Expand


Abstract​


Background: Early and accurate detection of the virus SARS-CoV-2, responsible for COVID-19 pandemic, is essential for controlling the disease spread. However, existing diagnostic platforms are constrained by cost, turnaround time, or limited sensitivity. Surface-enhanced Raman scattering (SERS) technique offers an attractive alternative, though conventional SERS substrates suffer from limited reproducibility and weak, non-specific analyte binding.


Results: This study presents developing a highly sensitive and selective signal-off SERS aptasensor for detecting SARS-CoV-2 by combining a gold-nanoparticle-embedded covalent organic framework (AuNPs@TtTp COF) substrate with Au@4ATP@Ag@Au core-shell SERS tags functionalized with the virus RBD (receptor binding domain)-specific DNA aptamer. Target-induced disassembly of the tag-aptamer-COF hotspot architecture produces a concentration-dependent decrease in SERS intensity, giving a detection limit of 1.3 × 10-17 g/mL over a dynamic range of 1 × 10-16 - 1 × 10-10 g/mL, with RSD values of 6.65 - 7.61% across replicate spots and substrates. Molecular dynamics simulations of three candidate aptamer-RBD complexes identifies the TZ1 model as most stable (binding free energy -57.99 kcal/mol). The aptasensor detects RBD in diluted human saliva, with results closely matching those of a commercial antigen test-kit.


Significance: By embedding gold nanoparticles within a triazine-linked COF and pairing them with dual-shell Au@4ATP@Ag@Au SERS tags, this platform achieves reproducible, ultrasensitive detection of the SARS-CoV-2 RBD, several orders of magnitude below other alternatives and outperforming previously reported SERS-based sensors for the same target. Because the design relies only on swapping the aptamer sequence to redirect target recognition, this strategy offers a readily adaptable template for rapid, low-cost diagnostics against other viral pathogens, and its performance in real saliva samples points toward a practical route from bench-scale detection to point-of-care screening.

Keywords: Aptasensor; Covalent organic framework (COF); RBD; SARS-CoV-2; Surface-enhanced Raman spectroscopy (SERS).
 
Back
Top Bottom